<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0045503</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1920</journal-id>
<journal-id journal-id-type="nlm-ta">Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Res.</journal-id>
<journal-title-group>
<journal-title>Brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8993</issn>
<issn pub-type="epub">1872-6240</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27125595</article-id>
<article-id pub-id-type="pmc">5003719</article-id>
<article-id pub-id-type="doi">10.1016/j.brainres.2016.04.020</article-id>
<article-id pub-id-type="manuscript">NIHMS783609</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pushing the threshold: how NMDAR antagonists induce homeostasis through protein synthesis to remedy depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Raab-Graham</surname>
<given-names>Kimberly F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Workman</surname>
<given-names>Emily R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Namjoshi</surname>
<given-names>Sanjeev</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niere</surname>
<given-names>Farr</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Center for Learning and Memory, Department of Neuroscience, Institute of Neuroscience</aff>
<aff id="A2"><label>2</label>Waggoner Center for Alcohol and Addiction Research</aff>
<aff id="A3"><label>3</label>Institute for Cell and Molecular Biology, University of Texas at Austin, Austin, Texas, 78712</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be addressed: Kimberly F. Raab-Graham, Center for Learning and Memory, Department of Neuroscience, University of Texas at Austin, 1 University Station C7000, Austin, TX 78712, USA, Tel: (512) 232-0892; Fax: (512) 475-8000; <email>Kimberly@mail.clm.utexas.edu</email></corresp>
<fn fn-type="present-address" id="FN2">
<label>4</label>
<p>Present Address: U.S. Army Institute of Surgical Research, Burns Injury and Regenerative Medicine Houston, United States</p>
</fn>
<fn fn-type="COI-statement" id="FN4">
<p>
<bold>Conflict of Interest</bold>
</p>
<p>Authors declare that the research was conducted in the absence of any commercial or financial interests that could be considered a conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>1647</volume>
<fpage>94</fpage>
<lpage>104</lpage>
<!--elocation-id from pubmed: 10.1016/j.brainres.2016.04.020-->
<abstract>
<p id="P2">Healthy neurons have an optimal operating range, coded globally by the frequency of action potentials or locally by calcium. The maintenance of this range is governed by homeostatic plasticity. Here, we discuss how new approaches to treat depression alter synaptic activity. These approaches induce the neuron to recruit homeostatic mechanisms to relieve depression. Homeostasis generally implies that the direction of activity necessary to restore the neuron’s critical operating range is opposite in direction to its current activity pattern. Unconventional antidepressant therapies deep brain stimulation and NMDAR antagonists alter the neuron’s “depressed” state by pushing the neuron’s current activity in the same direction but to the extreme edge. These therapies rally the intrinsic drive of neurons in the opposite direction, thereby allowing the cell to return to baseline activity, form new synapses, and restore proper communication. In this review, we discuss seminal studies on protein synthesis dependent homeostatic plasticity and their contribution to our understanding of molecular mechanisms underlying the effectiveness of NMDAR antagonists as rapid antidepressants. Rapid antidepressant efficacy is likely to require a cascade of mRNA translational regulation. Emerging evidence suggests that changes in synaptic strength or intrinsic excitability converge on the same protein synthesis pathways, relieving depressive symptoms. Thus, we address the question: Are there multiple homeostatic mechanisms that induce the neuron and neuronal circuits to self-correct to regulate mood <italic>in vivo</italic>? Targeting alternative ways to induce homeostatic protein synthesis may provide, faster, safer, and longer lasting antidepressants.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>